Neuroplasticity - Macher, Jean-Paul

. .

Résumé :
..

Biographie:
Jean-Paul Macher is a psychiatrist and researcher in Clinical Neurosciences. Dr Macher's main research areas are neuropsychopharmacology and functional brain imaging. He is a member of numerous societies in France, Europe and America, including the European College of NeuroPsychopharmacology (ECNP), Association of European Psychiatrists (AEP), Association Fran?aise de Psychiatrie Biologique (AFPB), Society for Mathematical Psychology (SMP), American Psychiatric Association (APA), Australasian Society of Biological Psychiatry (ASBP), European Sleep Research Society (ESRS), and the Chilean Association of Neurology, Psychiatry and Neurosurgery. Dr Macher is an expert on neuroscience, brain imaging and neuropsychopharmacology for the World Health Organization (WHO), President of the Research Methodology section of the World Psychiatric Association, and President of the International Foundation for Mental Health and Neurosciences. He is editor-in-chief of Dialogues in Clinical Neuroscience, and a member of the editorial boards of several journals. Dr Macher has written more than 200 scientific publications and many book chapters on neuropsychopharmacology. Jean-Pierre Oli? is Professor of Psychiatry at the Medical School of the University of Paris Descartes and Head of the Academic Department of Psychiatry at Sainte-Anne Hospital, Paris. He is a member of the Research Unit at INSERM on Pathophysiology of Mental Disorders. Dr Oli? was secretary of Association Fran?aise de Psychiatrie Biologique (AFPB) and is Past President of this French society. He has been a member of several different International Committees: Paris (2004) andMunich (2008) CINP, Paris (2009) World Federation Societies of Biological Psychiatry. Dr Oli? is also President of the Pierre Deniker Foundation, devoted to supporting research and teaching in psychiatry...

Sommaire:
Neuroplasticity ? A New Approach to the Pathophysiology of Depression.- Glutamate-Mediated Neuroplasticity Deficits in Mood Disorders.- Regulation of Cellular Plasticity in Mood Disorders: The Role of the AMPA Receptor.- Cellular Plasticity and the Pathophysiology of Depression.- Clinical Consequences of the Role of Glutamate and Neuroplasticity in Depressive Disorder.